DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Cholamandalam Investment and Finance Company Limited — Issue of Securities

NSE 57 min ago·28 Oct 2026, 7:59 am

Cholamandalam Investment and Finance Company

Cholamandalam Investment and Finance Company Limited has announced the issuance of new securities, a move that signals the company's intent to raise capital for growth. This action typically involves issuing fresh shares or bonds to the public or existing shareholders, which directly increases the company's equity base.

For investors, this development is significant as it provides fresh funds to the firm, potentially strengthening its balance sheet and supporting future business expansion. However, it also dilutes the ownership percentage of existing shareholders. The company's management will need to utilize these funds effectively to generate returns that justify the issuance.

Investors should closely monitor the company's future announcements regarding the specific use of these funds and the timing of the issue. Keeping an eye on the company's financial health and market performance following this capital infusion will be crucial to understanding the long-term impact on the stock.